LVRLF.OTC.PinkCordovacann CORP

20-F: CordovaCann Corp. Files 20-F Annual Report, Cites Ongoing Concerns Amidst Regulatory and Financial Challenges

Sentiment:

Annual Results


CordovaCann Corp.'s 20-F filing reveals a complex financial landscape with ongoing operational and regulatory challenges, despite a slight revenue increase.

Capital raiseThe company's ability to continue as a going concern is dependent upon its ability to access sufficient capital until it has profitable operations.To this point, all cashflow shortfall from operational activities and overhead costs have been funded through equity issuances, debt issuances and related party advances.The Company believes that continued funding from equity and debt issuances will provide sufficient cash flow for it to continue as a going concern in its present form until its operations become profitable and cash flow positive, however, there can be no assurances that the Company will achieve this.
Worse than expectedThe company's working capital deficit widened to $7,418,608, raising concerns about its ability to continue as a going concern.

Summary

  • CordovaCann Corp. reported a net loss of $1,275,056 for the fiscal year ended June 30, 2024, a significant improvement compared to the $6,917,910 loss in the previous year.
  • The company's revenue saw a slight increase to $13,797,150, up from $13,594,706 in 2023, primarily driven by its retail operations in Ontario and Manitoba.
  • Despite the revenue increase, the company's working capital deficit widened to $7,418,608, raising concerns about its ability to continue as a going concern.
  • The company's total assets decreased to $9,553,495, while total liabilities increased to $12,150,508.
  • The report highlights the complex regulatory environment in the U.S. cannabis industry, with federal laws conflicting with state-level legalization, creating risks for the company's investments.
  • The company's investments in the United States are subject to applicable anti-money laundering laws and regulations.
  • The company is subject to a variety of laws and regulations domestically and in the United States that involve money laundering, financial recordkeeping and proceeds of crime.
  • The company's investments, and any proceeds thereof, are considered proceeds of crime due to the fact that cannabis remains illegal federally in the United States.
  • The company's investments in the United States may be subject to heightened scrutiny by Canadian authorities.
  • The company's investments are subject to evolving regulation by governmental authorities.
  • The company's investments are subject to a variety of claims and lawsuits.
  • The company's investments are subject to inconsistent legislation, regulation, and enforcement.
  • The company's investments are subject to applicable anti-money laundering laws and regulations.
  • The company's investments, and any proceeds thereof, are considered proceeds of crime due to the fact that cannabis remains illegal federally in the United States.
  • The company's investments in the United States may be subject to heightened scrutiny by Canadian authorities.
  • The company's investments are subject to evolving regulation by governmental authorities.
  • The company's investments are subject to a variety of claims and lawsuits.
  • The company's investments are subject to inconsistent legislation, regulation, and enforcement.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive revenue growth but significant concerns about financial stability and regulatory risks. The overall sentiment is cautiously negative due to the going concern issues and the complex regulatory environment.

Positives

  • The company's net loss improved significantly to $1,275,056 in 2024, compared to a loss of $6,917,910 in 2023.
  • The company's revenue increased slightly to $13,797,150 in fiscal year 2024, up from $13,594,706 in 2023.
  • The company is focused on expanding its retail footprint, investing and scaling its branded product portfolio, and leveraging excess capacity for white label manufacturing.

Negatives

  • The company's working capital deficit widened to $7,418,608, raising concerns about its ability to continue as a going concern.
  • The company's total assets decreased to $9,553,495, while total liabilities increased to $12,150,508.
  • The company's investments, and any proceeds thereof, are considered proceeds of crime due to the fact that cannabis remains illegal federally in the United States.
  • The company's investments in the United States may be subject to heightened scrutiny by Canadian authorities.
  • The company's investments are subject to evolving regulation by governmental authorities.
  • The company's investments are subject to a variety of claims and lawsuits.
  • The company's investments are subject to inconsistent legislation, regulation, and enforcement.

Risks

  • The company's ability to continue as a going concern is dependent upon its ability to access sufficient capital until it has profitable operations.
  • The company's investments in the United States are subject to applicable anti-money laundering laws and regulations.
  • The company's investments, and any proceeds thereof, are considered proceeds of crime due to the fact that cannabis remains illegal federally in the United States.
  • The company's investments in the United States may be subject to heightened scrutiny by Canadian authorities.
  • The company's investments are subject to evolving regulation by governmental authorities.
  • The company's investments are subject to a variety of claims and lawsuits.
  • The company's investments are subject to inconsistent legislation, regulation, and enforcement.
  • The company's investments are subject to applicable anti-money laundering laws and regulations.
  • The company's investments, and any proceeds thereof, are considered proceeds of crime due to the fact that cannabis remains illegal federally in the United States.
  • The company's investments in the United States may be subject to heightened scrutiny by Canadian authorities.
  • The company's investments are subject to evolving regulation by governmental authorities.
  • The company's investments are subject to a variety of claims and lawsuits.
  • The company's investments are subject to inconsistent legislation, regulation, and enforcement.

Future Outlook

The Company is expecting to grow its retail operations both through development of new stores as well as looking for acquisition opportunities in strategic markets. CordovaCann is also focussing on growing its presence in the United States. Along with its growing operations in Oregon and Washington the Company is actively pursuing new opportunities in additional states to add to its portfolio, with its goal of having vertically integrated operations in key global cannabis markets. CordovaCann plans to develop various end products for distribution in each of its current markets as well as to service other brands and intellectual property owners with its growing processing and manufacturing platforms and allow these clients and prospective clients to gain access to our distribution channels to generate additional revenue for the Company.

Management Comments

  • Management continues to take an active approach to examining business opportunities in the cannabis industry that could enhance shareholder value.
  • The focus in the near term is to continue to grow its retail operations in Canada where the Company has established a presence in the provinces of Ontario and Manitoba.
  • CordovaCann is also focussing on growing its presence in the United States.

Industry Context

The report highlights the complex regulatory environment in the U.S. cannabis industry, with federal laws conflicting with state-level legalization, creating risks for the company's investments. The company is also subject to a variety of laws and regulations domestically and in the United States that involve money laundering, financial recordkeeping and proceeds of crime.

Comparison to Industry Standards

  • The company's financial performance is mixed, with a slight revenue increase but a widening working capital deficit, which is not uncommon for companies in the early stages of the cannabis industry.
  • The company's focus on retail, white-label manufacturing, and niche brands aligns with common strategies in the cannabis sector, but the success of these strategies will depend on execution and market conditions.
  • The company's reliance on debt financing and related party advances is a common practice for companies in the cannabis industry, but it also increases the company's financial risk.
  • The company's exposure to the complex regulatory environment in the U.S. is a common challenge for cannabis companies, and the company's ability to navigate these challenges will be critical to its success.
  • The company's focus on vertical integration is a common strategy in the cannabis industry, but it also requires significant capital investment and operational expertise.

Legal Proceedings

  • During the year ended June 30, 2023, the Company was identified as a defendant along with three other defendants (the Other Defendants) to a complaint in the Orange County Superior Court of California and for the State of California (the Complaint).
  • On November 1, 2024, the Company became aware of a lawsuit filed in the Ontario Superior Court of Justice on September 26, 2024, by 10330698 Canada Inc. (1033 Canada), claiming approximately $1,900,000 (the Claim).

Related Party Transactions

  • During the year ended June 30, 2024, the Company expensed $660,000 in fees payable to officers and directors of the Company and in fees payable to a corporation related by virtue of a common officer and director.
  • As at June 30, 2024, the Company had fees payable to officers and directors of the Company of $3,222,517.

Stakeholder Impact

  • Shareholders face the risk of dilution and potential loss of investment due to the company's financial instability and regulatory challenges.
  • Employees may be affected by potential restructuring or layoffs if the company's financial situation does not improve.
  • Customers may experience changes in product availability or service quality due to the company's operational challenges.
  • Suppliers and creditors face the risk of non-payment or delayed payments due to the company's financial difficulties.

Next Steps

  • The company is focused on expanding its retail footprint, investing and scaling its branded product portfolio, and leveraging excess capacity for white label manufacturing.
  • The company intends to leverage its low-cost infrastructure, administrative support, and move toward vertical integration in key markets to establish a global multi-jurisdictional platform.
  • CordovaCann continues to work with knowledgeable cannabis operators and over the next twelve months, the Company is focused on growing its retail operations in both Canada and the United States.
  • It is also working to expand the throughput of its wholesale operations as well as launch branded products in its U.S. markets.
  • Moving forward, the Company will also seek to enter additional key legal markets not currently served by CordovaCann, as well as seek to expand operations in those markets where the Company already has a presence.
  • CordovaCann plans to develop various end products for distribution in each of its current markets as well as to service other brands and intellectual property owners with its growing processing and manufacturing platforms and allow these clients and prospective clients to gain access to our distribution channels to generate additional revenue for the Company.

Key Dates

DateDescription
March 18, 1997CordovaCann was originally named Biolink Corp. and was formed as a result of an amalgamation.
October 20, 2006The Company completed its continuance from the OBCA to the Business Corporation Act (Canada).
January 3, 2018The Company changed its name to CordovaCann Corp.
May 19, 2020The Company completed the purchase of its initial stake of 2734158 Ontario Inc.
December 2, 2020The Company completed the purchase of a 51% stake in 10062771 Manitoba Ltd.
February 26, 2021Cordova WA entered into an agreement to acquire 100% of Extraction Technologies, LLC.
August 4, 2021The Company sold all of its land, building and equipment (the Oregon Property) and entered into an agreement to lease the Oregon Property from the buyer.
November 1, 2022The Company refinanced the existing Washington Mortgage.
June 30, 2024End of fiscal year.
December 13, 2024Date of the report.

Keywords

cannabis, retail, manufacturing, white label, investments, regulation, financial, operations, Canada, United States

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.